NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway
Article in Journal of Inflammation (June 2020)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Journal of Inflammation (June 2020)